english.prescrire.org > Spotlight > 100 most recent > In the June issue of Prescrire International - Strontium ranelate (Protelos°) for osteoporosis in men: more dangerous than beneficial

Spotlight

Every month, the subjects in Prescrire’s Spotlight.

100 most recent :  1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90

In the June issue of Prescrire International - Strontium ranelate (Protelos°) for osteoporosis in men: more dangerous than beneficial

FREE DOWNLOAD Strontium ranelate is used to treat postmenopausal osteoporosis in women. Serious and even life-threatening adverse effects have been reported since market release in 2005. The drug is now also licensed for the treatment of osteoporosis in men.
Full text available for free download.

Summary

  • Prevention of osteoporotic fractures in men should focus on non-drug measures, along with calcium and vitamin D supplementation if necessary.
     
  • Strontium ranelate should be avoided because it is more dangerous than beneficial.

Full text available for free download.

 ©Prescrire 1 June 2013

"Strontium ranelate for osteoporosis in men" Prescrire Int 2013; 22 (139): 150. (Pdf, free)
Download the full review
Pdf, free

See also:

Osteoporosis : avoid
strontium ranelate (Protelos°)
(March 2012)
Free

Osteoporosis: strontium
ranelate has too many
adverse effects
(June 2012)
Free